Published 2012 | Version v1
Journal article

H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma

  • 1. Huffington Center on Aging, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (United States)
  • 2. Health Science Center, University of Texas, 6431 Fannin Street, Houston, TX 77030 (United States)
  • 3. Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (United States)
  • 4. Department of Genome Dynamics, Lawrence Berkeley National Laboratory, University of California, Cyclotron Road, Berkeley, CA 94720 (United States)
  • 5. Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 (United States)
  • 6. Department of Dermatology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 (United States)
  • 7. Department of Dermatology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (United States)

Description

The current study characterizes the mitosis-associated histone dual modification on the core of histone H3: tri methylation of histone H3 lysine 79 and simultaneous phosphorylation of H3 threonine 80 (H3K79me3T80ph). Through the use of protein and microscopy-based techniques, we find that H3K79me3T80ph shares a similar spatial and temporal regulation as H3S10ph but additionally requires methyltransferase activity. In addition, we find that Aurora kinase activity is necessary for the catalysis of H3K79me3T80ph in vivo. Finally, our analysis of H3K79me3T80ph using a tissue micro array indicates that H3K79me3T80ph marks a subset of primary cutaneous melanomas with metastatic potential indicating that H3K79me3T80ph may identify a subset of invasive melanomas with a more aggressive clinical behaviour

Additional details

Publishing Information

Journal Title
Journal of Skin Cancer (Online)
Journal Volume
2012
Journal Issue
2012
Journal Page Range
9 p.
ISSN
2090-2913